Literature DB >> 8206722

Eosinophil granule major basic protein inhibition of corneal epithelial wound healing.

S D Trocmé1, G J Gleich, G M Kephart, J D Zieske.   

Abstract

PURPOSE: Human eosinophil major basic protein (MBP) was studied in an established organ culture model for rat corneal epithelial wound healing to elucidate further the role of the protein in vernal keratopathy.
METHODS: Epithelial migration rates were tested for five MBP concentrations (10, 25, 50, 100, and 200 micrograms/ml MBP).
RESULTS: Significantly less epithelial migration than control (P < 0.05) was observed in all tested groups. Histologic examination revealed abnormally heaped-up leading epithelial edges in all test groups compared to the normal tapered edges in all controls. Immunofluorescence disclosed MBP deposition on deepithelialized cornea.
CONCLUSIONS: These results suggest that MBP may contribute to vernal corneal ulcerations by inhibiting corneal epithelial migration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206722

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 2.  Pathogenesis of onchocercal keratitis (River blindness).

Authors:  L R Hall; E Pearlman
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

Review 3.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

4.  Eosinophil cationic protein in tears in allergic conjunctivitis.

Authors:  P G Montan; M van Hage-Hamsten
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

Review 5.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

6.  Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis.

Authors:  K Yokoi; N Yokoi; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

7.  Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.

Authors:  A Leonardi; D Bremond-Gignac; M Bortolotti; D Violato; P Pouliquen; L Delval; J M Grouin; I A Fregona
Journal:  Br J Ophthalmol       Date:  2007-06-21       Impact factor: 4.638

Review 8.  Role of Damage-Associated Molecular Patterns (DAMPs/Alarmins) in Severe Ocular Allergic Diseases.

Authors:  Ken Fukuda; Waka Ishida; Tatsuma Kishimoto; Isana Nakajima; Yusaku Miura; Tamaki Sumi; Kenji Yamashiro
Journal:  Cells       Date:  2022-03-20       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.